NCT04752267
- Conditions
- Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +65 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Prognostic Stage IV Breast Cancer AJCC v8
Explore clinical trials studying Prognostic Stage IV Breast Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
37 public trials
9 recruiting studies
Prognostic Stage IV Breast Cancer AJCC v8 trial results
NCT03853707
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT04297384
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Breast Diseases, +8 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT03524170
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
NCT03106077
- Conditions
- Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
IACS-010759 in Advanced Cancers
NCT03291938
- Conditions
- Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer
NCT03544125
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT00338728
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
NCT04616248
- Conditions
- Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Basal Cell Carcinoma, +44 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States